The FDA and the pharmaceutical companies have come up with a new proposal for a program that charges drugmakers fees to speed up FDA approval process, but critics say it doesn't do enough to protect consumers.
One of the factors often cited as contributing to high health-care costs is the money paid to executives of medical and drug companies. Helen Palmer looks at whether the bosses are worth what they get.
The Mountain State is about to put its Medicaid population on a diet run by the weight-loss company in an attempt to reduce the $100 million a year it spends in obesity-related medical costs. Helen Palmer reports.
In his State of the Union address, President Bush proposed a new approach to healthcare funding that would mean changes to most tax bills. Marketplace health reporter Helen Palmer talks with Kai Ryssdal about the idea.
American children of different races aren't growing up in a world of equal opportunity, according to data collected by researchers as part of a new project exploring diversity in U.S. metro areas. Helen Palmer reports.